文献速递胃肠外科

第四空间手术:内镜下浆膜下剥离术治疗上消化道固有肌层来源的黏膜下肿瘤

The fourth space surgery: endoscopic subserosal dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria layer.
PubMed 文献 · Surg Endosc · 2017-12-20

该研究开发了内镜下浆膜下剥离术(ESSD)用于切除上消化道固有肌层(MP)来源的黏膜下肿瘤(SETs),11例患者接受治疗,完整切除率100%,平均手术时间51分钟,2例术中发生小穿孔均内镜下闭合,随访期间无残留或复发,认为ESSD有效、安全且微创。

要点

  • ESSD治疗上消化道MP层SETs完整切除率100%,平均手术时间51分钟。
  • 术中2例发生小穿孔(4×4和5×5 mm),均经内镜下成功闭合。
  • 随访无病变残留或复发,无消化道出血、腹膜炎等不良事件。

核心结论

  • ESSD对于上消化道固有肌层来源的黏膜下肿瘤似乎是有效、安全且微创的治疗方法,可切除深部病变、提供精确病理诊断并保持浆膜完整性。

研究设计与样本

  • 单臂研究,2016年10月至2017年3月纳入11例上消化道固有肌层来源的黏膜下肿瘤患者接受ESSD治疗。
  • ESSD技术包括六个主要步骤:切开病变周围黏膜及黏膜下层暴露固有肌层;注射针从固有肌层向浆膜下层缓慢移动并持续注射;切开固有肌层;浆膜下注射进一步分离浆膜与固有肌层;整块剥离包含肿瘤的黏膜、黏膜下层及固有肌层;内镜下闭合胃壁缺损。
  • 主要结局包括临床操作成功率和操作相关不良事件。

主要发现

  • ESSD在11例患者中均成功完成。
  • 完整切除率为100%,平均手术时间51分钟(范围22-76分钟)。
  • 平均切除病变大小27毫米(范围15-40毫米)。
  • 病理诊断包括胃肠间质瘤(8/11)、异位胰腺(1/11)、错构瘤(1/11)和平滑肌瘤(1/11)。
  • 术中2例发生小穿孔(分别为4×4毫米和5×5毫米),所有穿孔和缺损均经内镜下技术成功闭合,未观察到消化道出血、腹膜炎、腹腔脓肿及其他不良事件。

临床怎么用

  • ESSD可作为上消化道固有肌层来源黏膜下肿瘤的微创治疗选择,尤其适用于需要切除深部病变并获取精确病理诊断的病例。
  • 术中发生小穿孔可通过内镜下技术成功闭合,但需具备相应的内镜缝合技术。

局限性

  • 样本量小(11例),随访时间较短(平均18周,范围10-29周)。
  • 单臂研究,缺乏对照组。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: We developed a novel method of endoscopic subserosal dissection (ESSD) for removal of subepithelial tumors (SETs) originating from the muscularis propria (MP) layer in the upper gastrointestinal (GI) tract. The aim of this study was to evaluate the efficacy, safety, and clinical outcome of this method. METHODS: Eleven patients with upper GI SETs originating from the MP layer were treated by ESSD between October 2016 and March 2017. ESSD technique consists of six major procedures: (1) incising the mucosal and submucosal layer around the lesion and exposing MP layer; (2) continuous injection was performed while the injection needle slowly moved from the MP layer toward the subserosal layer; (3) incising MP layer; (4) subserosal injection was performed to further separate the serosa from the MP layer; (5) the mucosa, submucosa, and MP layer including SET were carefully dissected en bloc; and (6) closure of the gastric-wall defect with endoscopic techniques. Primary outcome including clinical procedural success and procedure-related adverse events were documented. RESULTS: ESSD was successfully performed in 11 patients. The complete resection rate was 100%, and the mean operation time was 51 (range 22-76) min. The mean resected lesion size was 27 (range 15-40) mm. Pathological diagnosis of these lesions included gastrointestinal stromal tumors (8/11), heterotopic pancreas (1/11), hamartoma (1/11), and leiomyoma (1/11). The small perforations occurred in two patients (4 × 4 and 5 × 5 mm, respectively) during the operation. All perforations and defects were closed successfully by endoscopic techniques. No GI bleeding, peritonitis, abdominal abscess, and other adverse events were observed. No lesion residual or recurrence was found during the follow-up period (mean 18 weeks; range 10-29 weeks). CONCLUSION: ESSD seems to be an efficacious, safe, and minimally invasive treatment for patients with upper GI SETs originating from the MP layer, making it possible to resect deep lesions, provide precise pathological diagnosis, and maintain the integrity of serosa.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Liu F, Zhang S, Ren W, et al. The fourth space surgery: endoscopic subserosal dissection for upper gastrointestinal subepithelial tumors originating from the muscularis propria layer. Surg Endosc. 2017. PMID: 29264757. doi:10.1007/s00464-017-5985-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。